loading

Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
0.60%
55.26
55.59 75.80 55.00 48.85
Operating Income/Loss
0.60%
-55.26
-55.59 -75.80 -55.00 -48.85
Income/Loss From Continuing Operations Before Tax
0.20%
-50.71
-50.61 -70.06 -48.50 -40.56
Income/Loss From Continuing Operations After Tax
0.20%
-50.71
-50.61 -70.06 -48.50 -40.56
Net Income/Loss
0.20%
-50.71
-50.61 -70.06 -48.50 -40.56
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):